California Innovation Fund
California Innovation Fund, established in 2021 and based in Berkeley, California, is a venture capital firm dedicated to supporting early-stage startups affiliated with the University of California system. The fund provides venture funding ranging from $250,000 to $1 million, with reserves for follow-on investments, focusing on late seed and Series A rounds. California Innovation Fund emphasizes its commitment to nurturing the entrepreneurial ecosystem by reinvesting 50% of its profits back into the public University of California system. The firm is backed by a community of UC alumni, faculty, successful entrepreneurs, and industry leaders who collectively aim to assist startups in addressing significant challenges and promoting positive societal outcomes. By leveraging this network and financial resources, California Innovation Fund seeks to empower entrepreneurs in their pursuit of innovative solutions for the public good.
SixMap is an information technology company that focuses on external attack surface management. It has developed a platform designed to detect and remediate network security policies by providing organizations with insights into their network vulnerabilities from an attacker's perspective. This technology enables businesses to effectively monitor their attack surfaces and plan their response during cyber attacks, enhancing their overall cybersecurity posture. SixMap specializes in network security and software solutions, addressing the growing need for robust security measures in an increasingly digital landscape.
Engage Bio is developing mRNA treatments that change cancer cells into production facilities for immunotherapies. With the help of these treatments, the immune system is activated and directed toward the tumour.
Calyx is a material science and Internet of Things (IoT) platform company that leverages biological principles to develop low-cost and highly accurate sensors for real-time detection and analysis of air chemicals. Founded in 2014 and rebranded from BioInspira in 2019, Calyx serves various sectors, including industrial safety, healthcare, transportation, and food markets. The company's innovative sensor technology is designed to enhance monitoring applications, including health and air quality assessments, along with ensuring safety in natural gas infrastructure. Based in Berkeley, California, Calyx is focused on providing solutions that improve safety and efficiency across multiple industries.
Selva Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for infectious diseases. Headquartered in San Diego, California, the company was incorporated in 2017 and is dedicated to addressing global health threats. Its lead product, SLV213, is an orally available small molecule antiviral therapy that exhibits activity against a range of viruses, including SARS-CoV-2, which causes COVID-19, as well as Ebola, Nipah, and parasites associated with Chagas disease. SLV213 works by binding to receptors necessary for viral entry into human lung cells, offering potential as both a standalone treatment and in combination with other direct-acting antivirals.
Catena Biosciences is a biotechnology startup emerging from research at UC Berkeley, focused on developing innovative treatments for autoimmune disorders. The company has created an advanced protein coupling technology that allows for the rapid and selective fusion of proteins using natural amino acids, specifically tyrosine and cysteine. This method enhances the ability of researchers to design novel therapeutics not only for autoimmune disorders but also for oncology and vaccine development. By leveraging this unique platform, Catena Biosciences aims to transform the landscape of treatment options for these challenging medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.